Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
France debates the sale of its top painkiller, Doliprane, to US investors, raising national sovereignty concerns.
France is debating the proposed sale of Doliprane, its top-selling painkiller, to US investors, sparking concerns over national sovereignty.
Sanofi is negotiating with private equity firm Clayton, Dubilier & Rice to sell a 50% stake in its subsidiary Opella.
French officials demand that Opella's headquarters and decision-making remain in France, emphasizing job security and production guarantees.
Without compliance, the government may block the deal or seek state involvement.
13 Articles
Francia debate la venta de su mejor analgésico, Doliprane, a inversores estadounidenses, planteando preocupaciones de soberanía nacional.